Encephalopathy - Pipeline Review, H2 2017 - Aarkstore
Latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy - Pipeline Review, H2 2017, provides an overview of the Encephalopathy (Central Nervous System) pipeline landscape. Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. Symptoms include seizures, difficulty speaking or swallowing, trembling, involuntary twitching and muscle weakness. Causes include traumas or injuries, genetic, liver disease, hypoxic condition, Lyme disease and organ failure. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Encephalopathy - Pipeline Review, H2 2017 , provides comprehensive information on the therapeutics under development for Encephalopathy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete ...